Replies to post #212179 on Biotech Values

[DewDiligence]

AKBA sells 9.78M* shares @10.50—a 12.5% discount to yesterday’s close—and a 28% discont to AKBA's previous financing 9 months ago:

https://finance.yahoo.com/news/akebia-therapeutics-announces-pricing-public-120000597.html

*Assuming exercise of underwriter’s option.